Company Filing History:
Years Active: 2009
Title: Paul Antony Cullen: Innovator in Nucleic Acid Sequences
Introduction
Paul Antony Cullen is a notable inventor based in Murrumbeena, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid sequences. His work focuses on immunogenic fragments and their applications in vaccines.
Latest Patents
Cullen holds a patent related to nucleic acid sequences encoding a 30 kD lipoprotein. This invention encompasses various aspects, including DNA fragments, recombinant DNA molecules, and live recombinant carriers. The patent also covers the use of these sequences in vaccines and diagnostic kits, highlighting their potential in both therapeutic and diagnostic applications.
Career Highlights
Cullen is associated with Intervet International B.V., where he has been instrumental in advancing research in immunology and vaccine development. His innovative approach has led to the creation of valuable biotechnological solutions.
Collaborations
Cullen has worked alongside notable colleagues such as Ben Adler and Scott Adam James Coutts. Their collaborative efforts have contributed to the advancement of research in their respective fields.
Conclusion
Paul Antony Cullen's work in nucleic acid sequences and immunogenic fragments showcases his dedication to innovation in biotechnology. His contributions have the potential to impact vaccine development and diagnostic methods significantly.